Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-26

HgCapital TrustadminNew Director · Appointment of ALI, Moynul as director · New director appointed · board evolution4 days ago

HgCapital Trust4 days ago

New Director · Appointment of ALI, Moynul as director · New director appointed · board evolution

admin

Treble PeakcapitalShare Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal5 days ago

Treble Peak5 days ago

Share Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Compagnie Financière et de Participations RoullieradminBoard change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board2 weeks ago

Compagnie Financière et de Participations Roullier2 weeks ago

Board change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Lauxera Capital Partners1 month ago

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin

Biotech United Kingdom

72 companies matching · Page 1 of 2

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Myricx Bio3 periods Abingworth Bioventures 8	Biotech	United Kingdom	Abingworth	2022	4yr	Exited 2026	Novartis	–
Verona Pharma3 periods Sofinnova Crossover Fund I	Biotech	United Kingdom	Sofinnova Partners	2016	6yr	Exited 2025	Merck & Co.	–
ReNeuron Group Obotritia Capital KGaA	Biotech	United Kingdom	Obotritia Capital	–	–	Exited 2024	–	–
ReViral BioDiscovery 4	Biotech	United Kingdom	Andera Partners	2015	7yr	Exited 2022	Pfizer	–
Achilles Therapeutics Albion Enterprise VCT	Biotech	United Kingdom	Albion Capital	2016	5yr	Exited 2021	–	–
Compass Pathways Principia III - Health	Biotech	United Kingdom	Principia SGR	2018	2yr	Exited 2020	–	–
Delinia Sofinnova Capital VIII	Biotech	United Kingdom	Sofinnova Partners	2016	1yr	Exited 2017	Celgene	–
Fusion Antibodies Co-Fund NI	Biotech	United Kingdom	Clarendon Fund Managers	2013	4yr	Exited 2017	–	–
Atopix Therapeutics Wellington Partners Life Sciences	Biotech	United Kingdom	Wellington Partners	2013	3yr	Exited 2016	Chiesi Farmaceutici	–
Artios Pharma4 periods Sofinnova Crossover Fund I	Biotech	United Kingdom	Sofinnova Partners	2016	10yr	Active	–	–
Microbiotica4 periods Health for Life Capital	Biotech	United Kingdom	Seventure Partners	2016	10yr	Active	–	–
Crescendo Biologics3 periods BioDiscovery 5	Biotech	United Kingdom	Andera Partners	2018	8yr	Active	–	–
T-Therapeutics3 periods BGF	Biotech	United Kingdom	BGF	2023	3yr	Active	–	–
F2G2 periods Sofinnova Crossover Fund I	Biotech	United Kingdom	Sofinnova Partners	2010	16yr	Active	–	–
GreyWolf Therapeutics2 periods Earlybird Health	Biotech	United Kingdom	Earlybird Venture Capital	2018	8yr	Active	–	–
Immunocore2 periods Rosetta Capital V	Biotech	United Kingdom	Rosetta Capital	2021	5yr	Active	–	–
Mission Therapeutics2 periods Rosetta Capital V	Biotech	United Kingdom	Rosetta Capital	2019	7yr	Active	–	–
NodThera2 periods Sofinnova Capital X	Biotech	United Kingdom	Sofinnova Partners	2020	6yr	Active	–	–
Quell Therapeutics2 periods SV7 Impact Medicine Fund	Biotech	United Kingdom	SV Health Managers	2021	5yr	Active	–	–
Scripta2 periods YZR Capital Fund I	Biotech	United Kingdom	YZR Capital	2025	1yr	Active	–	–
Sitryx Therapeutics2 periods Sofinnova Capital X	Biotech	United Kingdom	Sofinnova Partners	2018	8yr	Active	–	–
4basebio PLC Deutsche Balaton Evergreen Holding (Balance Sheet)	Biotech	United Kingdom	Deutsche Balaton Aktiengesellschaft	2021	5yr	Active	–	–
Aglaris CRB Bio II	Biotech	United Kingdom	CRB Health Tech	2016	10yr	Active	–	–
Amply Co-Fund NI	Biotech	United Kingdom	Clarendon Fund Managers	2022	4yr	Active	–	–
Bindbridge Nucleus Capital II	Biotech	United Kingdom	Nucleus Capital	2026	0yr	Active	–	–
bit.bio BlueYard Capital Fund II	Biotech	United Kingdom	BlueYard Capital	2019	7yr	Active	–	–
Bright Biotech FoodLabs Fund II	Biotech	United Kingdom	FoodLabs	2022	4yr	Active	–	–
Centauri Therapeutics Boehringer Ingelheim Venture Fund	Biotech	United Kingdom	Boehringer Ingelheim Venture Fund	2022	4yr	Active	–	–
clock.bio BlueYard Capital Fund III	Biotech	United Kingdom	BlueYard Capital	2024	2yr	Active	–	–
Concert Bio Nucleus Capital I	Biotech	United Kingdom	Nucleus Capital	2022	4yr	Active	–	–
Creasallis BlueYard Capital Fund III	Biotech	United Kingdom	BlueYard Capital	2023	3yr	Active	–	–
Curve Therapeutics Columbus Life Sciences Fund IV	Biotech	United Kingdom	Columbus Venture Partners	2024	2yr	Active	–	–
DunAD Therapeutics Wellington Partners Life Sciences	Biotech	United Kingdom	Wellington Partners	2021	5yr	Active	–	–
Elevara Medicines Sofinnova Capital X	Biotech	United Kingdom	Sofinnova Partners	2022	4yr	Active	–	–
Enterprise Therapeutics Panakes Fund Purple	Biotech	United Kingdom	Panakes Partners SGR	2024	2yr	Active	–	–
Glox Therapeutics Boehringer Ingelheim Venture Fund	Biotech	United Kingdom	Boehringer Ingelheim Venture Fund	2023	3yr	Active	–	–
Lifebit Idinvest Digital Fund III	Biotech	United Kingdom	Eurazeo	2019	7yr	Active	–	–
Maxion Therapeutics LifeArc Ventures	Biotech	United Kingdom	LifeArc	2023	3yr	Active	–	–
Mironid Sofinnova Capital X	Biotech	United Kingdom	Sofinnova Partners	2021	5yr	Active	–	–
NuCana Sofinnova Capital VIII	Biotech	United Kingdom	Sofinnova Partners	2015	11yr	Active	–	–
Outpost Bio Merantix Capital AI Fund	Biotech	United Kingdom	Merantix Capital	2025	1yr	Active	–	–
Purespring Sofinnova Capital X	Biotech	United Kingdom	Sofinnova Partners	2021	5yr	Active	–	–
Redona Therapeutics Sofinnova Capital X	Biotech	United Kingdom	Sofinnova Partners	2022	4yr	Active	–	–
Relation Therapeutics Hitachi Ventures Fund III	Biotech	United Kingdom	Hitachi Ventures	2024	2yr	Active	–	–
RinRi Therapeutics Boehringer Ingelheim Venture Fund	Biotech	United Kingdom	Boehringer Ingelheim Venture Fund	2019	7yr	Active	–	–
Roslinct GHO Capital III LP	Biotech	United Kingdom	GHO Capital	2021	5yr	Active	–	–
Samsara Therapeutics Apollo Health Ventures Fund I	Biotech	United Kingdom	Apollo Health Ventures	2019	7yr	Active	–	–
Synthace Sofinnova Crossover Fund I	Biotech	United Kingdom	Sofinnova Partners	2019	7yr	Active	–	–
Twig Bio Project A Ventures IV	Biotech	United Kingdom	Project A Ventures	2023	3yr	Active	–	–
VascVersa Co-Fund NI	Biotech	United Kingdom	Clarendon Fund Managers	2021	5yr	Active	–	–

Portfolio companies.21,000+ PE-backed.

Portfolio companies.
21,000+ PE-backed.